Search

Search Constraints

You searched for: Author/Creator Khochenkov, Dmitry

Search Results

1. Corrigendum to 'Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models' [Eur J Cancer 61 (2016) 20–28]. (January 2017)

2. MBCL-04. 5 – AZACYTIDINE IN TREATMENT OF CHILDREN WITH DE NOVO AND RELAPSED METASTATIC MEDULLOBLASTOMA: RESULTS OF INTERCENTER PILOT STUDY. (4th December 2020)

3. MBCL-05. TREATMENT OF CHILDREN WITH MEDULLOBLASTOMA WITHOUT METASTATIC INVOLVEMENT IN THE AGE GROUP OLDER THAN 3 YEARS: RESULTS OF INTERCENTER TRIAL. (4th December 2020)

4. MBCL-20. MGMT PROTEIN EXPRESSION AND MGMT GENE PROMOTER METHYLATION AS MARKERS OF DRUG SENSITIVITY TO EPIGENETIC THERAPY IN CHILDHOOD MEDULLOBLASTOMA. Issue 2 (22nd June 2018)

5. MEDU-12. TREATMENT RESULTS OF CHILDREN WITH METASTATIC MEDULLOBLASTOMA ACCORDING TO C-MYC/N-MYC/Iso17q AND MGMT TUMOR STATUS. (23rd April 2019)

6. Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models. (July 2016)